{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:19:46Z","timestamp":1790734786950,"version":"4.1.0"},"reference-count":30,"publisher":"IMR Press","issue":"1","license":[{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Background: Systemic inflammation can occur after transcatheter aortic valve replacement (TAVR) and correlates with adverse outcome. The impact of remote ischemic preconditioning (RIPC) on TAVR associated systemic inflammation is unknown and was focus of this study. Methods: We performed a prospective controlled trial at a single center and included 66 patients treated with remote ischemic preconditioning (RIPC) prior to TAVR, who were matched to a control group by propensity score. RIPC was applied to the upper extremity using a conventional tourniquet. Definition of systemic inflammation was based on leucocyte count, C-reactive protein (CRP), procalcitonin (PCT) and interleukin-6 (IL-6), assessed in the first 5 days following the TAVR procedure. Mortality was determined within 6 months after TAVR. RIPC group and matched control group showed comparable baseline characteristics. Results: Systemic inflammation occurred in 66% of all patients after TAVR. Overall, survival after 6 months was significantly reduced in patients with systemic inflammation. RIPC, in comparison to control, did not significantly alter the plasma levels of leucocyte count, CRP, PCT or IL-6 within the first 5 days after TAVR. Furthermore, inflammation associated survival after 6 months was not improved by RIPC. Of all peri-interventional variables assessed, only the amount of the applied contrast agent was connected to the occurrence of systemic inflammation. Conclusions: Systemic inflammation frequently occurs after TAVR and leads to increased mortality after 6 months. RIPC neither reduces the incidence of systemic inflammation nor improves inflammation associated patient survival within 6 months.<\/jats:p>","DOI":"10.31083\/j.rcm2301020","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T08:58:19Z","timestamp":1642237099000},"source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of systemic inflammation in response to remote ischemic preconditioning in patients undergoing transcatheter aortic valve replacement (TAVR)"],"prefix":"10.31083","volume":"23","author":[{"given":"Kun","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Cardiology, Campus Virchow-Klinikum, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany"},{"name":"Berlin Health Institute, 10178 Berlin, Germany"},{"name":"DZHK (German Centre for Cardiovascular Research), partner site Berlin, 10785 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willi","family":"Troeger","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Cardiology, Faculty of Medicine Carl Gustav Carus at Technische Universit\u00e4t Dresden, Herzzentrum Dresden, 01307 Dresden, Germany"},{"name":"Department of Anesthesiology and Critical Care Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kuhn","sequence":"first","affiliation":[{"name":"Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, Technische Universit\u00e4t Dresden, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Wiedemann","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Cardiology, HELIOS Klinikum Pirna, 01796 Pirna, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Ibrahim","sequence":"first","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine Carl Gustav Carus at Technische Universit\u00e4t Dresden, Klinikum Chemnitz, 09116 Chemnitz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pfluecke","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Cardiology, Faculty of Medicine Carl Gustav Carus at Technische Universit\u00e4t Dresden, Herzzentrum Dresden, 01307 Dresden, Germany"},{"name":"Department of Internal Medicine I, Faculty of Medicine Carl Gustav Carus at Technische Universit\u00e4t Dresden, Klinikum G\u00f6rlitz, 02828 G\u00f6rlitz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krunoslav M.","family":"Sveric","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Cardiology, Faculty of Medicine Carl Gustav Carus at Technische Universit\u00e4t Dresden, Herzzentrum Dresden, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Winzer","sequence":"first","affiliation":[{"name":"Department of Radiology, Faculty of Medicine Carl Gustav Carus at Technische Universit\u00e4t Dresden, Universit\u00e4tsklinikum Dresden, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Fedders","sequence":"first","affiliation":[{"name":"Department of Radiology, Faculty of Medicine Carl Gustav Carus at Technische Universit\u00e4t Dresden, Universit\u00e4tsklinikum Dresden, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias F.","family":"Ruf","sequence":"first","affiliation":[{"name":"Center for Cardiology I, Heart Valve Center Mainz, University Medical Center Mainz, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth H.","family":"Strasser","sequence":"first","affiliation":[{"name":"Faculty of Medicine Carl Gustav Carus, Technische Universit\u00e4t Dresden, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Linke","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Cardiology, Faculty of Medicine Carl Gustav Carus at Technische Universit\u00e4t Dresden, Herzzentrum Dresden, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Quick","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Cardiology, Faculty of Medicine Carl Gustav Carus at Technische Universit\u00e4t Dresden, Herzzentrum Dresden, 01307 Dresden, Germany"},{"name":"Department of Cardiology, Faculty of Medicine Carl Gustav Carus at Technische Universit\u00e4t Dresden, Klinikum Chemnitz, 09116 Chemnitz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix M.","family":"Heidrich","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Cardiology, Faculty of Medicine Carl Gustav Carus at Technische Universit\u00e4t Dresden, Herzzentrum Dresden, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2022,1,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002; 106: 3006\u20133008.","DOI":"10.1161\/01.CIR.0000047200.36165.B8"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Kumar V, Sandhu GS, Harper CM, Ting HH, Rihal CS. Transcatheter Aortic Valve Replacement Programs: Clinical Outcomes and Developments. Journal of the American Heart Association. 2020; 9: e015921.","DOI":"10.1161\/JAHA.120.015921"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Gorla R, Erbel R, Eagle KA, Bossone E. Systemic inflammatory response syndromes in the era of interventional cardiology. Vascular Pharmacology. 2018; 107: 53\u201366.","DOI":"10.1016\/j.vph.2018.04.003"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Sinning JM, Scheer AC, Adenauer V, Ghanem A, Hammerstingl C, Schueler R, et al. Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation. European Heart Journal. 2012; 33: 1459\u20131468.","DOI":"10.1093\/eurheartj\/ehs002"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Lindman BR, Goldstein JS, Nassif ME, Zajarias A, Novak E, Tibrewala A, et al. Systemic inflammatory response syndrome after transcatheter or surgical aortic valve replacement. Heart. 2015; 101: 537\u2013545.","DOI":"10.1136\/heartjnl-2014-307057"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA, et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation. 2002; 106: 2881\u20132883.","DOI":"10.1161\/01.CIR.0000043806.51912.9B"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Heusch G, Botker HE, Przyklenk K, Redington A, Yellon D. Remote ischemic conditioning. Journal of the American College of Cardiology. 2015; 65: 177\u2013195.","DOI":"10.1016\/j.jacc.2014.10.031"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Konstantinov IE, Arab S, Kharbanda RK, Li J, Cheung MM, Cherepanov V, et al. The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans. Physiological Genomics. 2004; 19: 143\u2013150.","DOI":"10.1152\/physiolgenomics.00046.2004"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Cai ZP, Parajuli N, Zheng X, Becker L. Remote ischemic preconditioning confers late protection against myocardial ischemia-reperfusion injury in mice by upregulating interleukin-10. Basic Research in Cardiology. 2012; 107: 277.","DOI":"10.1007\/s00395-012-0277-1"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Otto CM, Baumgartner H. Updated 2017 European and American guidelines for prosthesis type and implantation mode in severe aortic stenosis. Heart. 2018; 104: 710\u2013713.","DOI":"10.1136\/heartjnl-2017-312487"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Critical Care Medicine. 2003; 31: 1737\u20131741.","DOI":"10.1097\/01.CCM.0000063440.19188.ED"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Ma L, Zhang H, Yin YL, Guo WZ, Ma YQ, Wang YB, et al. Role of interleukin-6 to differentiate sepsis from non-infectious systemic inflammatory response syndrome. Cytokine. 2016; 88: 126\u2013135.","DOI":"10.1016\/j.cyto.2016.08.033"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. The New England Journal of Medicine. 2010; 363: 1597\u20131607.","DOI":"10.1056\/NEJMoa1008232"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Ho D, Imai K, King G, Stuart EA. MatchIt: Nonparametric Preprocessing for Parametric Causal Inference. Journal of Statistical Software. 2011; 42: 1\u201328.","DOI":"10.18637\/jss.v042.i08"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Rettig TCD, Nijenhuis VJ, Meek B, Rigter S, Ten Berg JM, Vlaminckx B, et al. Systemic Inflammation after Transcatheter Aortic Valve Implantation: A Prospective Exploratory Study. Journal of Cardiothoracic and Vascular Anesthesia. 2018; 32: e77\u2013e82.","DOI":"10.1053\/j.jvca.2017.12.051"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Sinning JM, Ghanem A, Steinhauser H, Adenauer V, Hammerstingl C, Nickenig G, et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC: Cardiovascular Interventions. 2010; 3: 1141\u20131149.","DOI":"10.1016\/j.jcin.2010.09.009"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Bagur R, Webb JG, Nietlispach F, Dumont E, De Larochelliere R, Doyle D, et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. European Heart Journal. 2010; 31: 865\u2013874.","DOI":"10.1093\/eurheartj\/ehp552"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Nuis RJ, Van Mieghem NM, Tzikas A, Piazza N, Otten AM, Cheng J, et al. Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation. Catheterization and Cardiovascular Interventions. 2011; 77: 881\u2013889.","DOI":"10.1002\/ccd.22874"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Vincent JL, Opal SM, Marshall JC, Tracey KJ. Sepsis definitions: time for change. Lancet. 2013; 381: 774\u2013775.","DOI":"10.1016\/S0140-6736(12)61815-7"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Diegeler A, Doll N, Rauch T, Haberer D, Walther T, Falk V, et al. Humoral immune response during coronary artery bypass grafting: A comparison of limited approach, \u201doff-pump\u201d technique, and conventional cardiopulmonary bypass. Circulation. 2000; 102: III95-100.","DOI":"10.1161\/01.CIR.102.suppl_3.III-95"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Sablotzki A, Friedrich I, Muhling J, Dehne MG, Spillner J, Silber RE, et al. The systemic inflammatory response syndrome following cardiac surgery: different expression of proinflammatory cytokines and procalcitonin in patients with and without multiorgan dysfunctions. Perfusion. 2002; 17: 103\u2013109.","DOI":"10.1177\/026765910201700206"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Franke A, Lante W, Fackeldey V, Becker HP, Kurig E, Zoller LG, et al. Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know? European Journal of Cardio-Thoracic Surgery. 2005; 28: 569\u2013575.","DOI":"10.1016\/j.ejcts.2005.07.007"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Asimakopoulos G. Mechanisms of the systemic inflammatory response. Perfusion. 1999; 14: 269\u2013277.","DOI":"10.1177\/026765919901400406"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Kohsaka S, Menon V, Lowe AM, Lange M, Dzavik V, Sleeper LA, et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Archives of Internal Medicine. 2005; 165: 1643\u20131650.","DOI":"10.1001\/archinte.165.14.1643"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Hausenloy DJ, Yellon DM. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovascular Research. 2008; 79: 377\u2013386.","DOI":"10.1093\/cvr\/cvn114"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet. 2010; 375: 727\u2013734.","DOI":"10.1016\/S0140-6736(09)62001-8"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Candilio L, Malik A, Ariti C, Barnard M, Di Salvo C, Lawrence D, et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart. 2015; 101: 185\u2013192.","DOI":"10.1136\/heartjnl-2014-306178"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Thielmann M, Kottenberg E, Kleinbongard P, Wendt D, Gedik N, Pasa S, et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet. 2013; 382: 597\u2013604.","DOI":"10.1016\/S0140-6736(13)61450-6"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Flechsig M, Ruf TF, Troeger W, Wiedemann S, Quick S, Ibrahim K, et al. Remote Ischemic Preconditioning Neither Improves Survival nor Reduces Myocardial or Kidney Injury in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI). Journal of Clinical Medicine. 2020; 9: 160.","DOI":"10.3390\/jcm9010160"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Kahlert P, Hildebrandt HA, Patsalis PC, Al-Rashid F, Janosi RA, Nensa F, et al. No protection of heart, kidneys and brain by remote ischemic preconditioning before transfemoral transcatheter aortic valve implantation: Interim-analysis of a randomized single-blinded, placebo-controlled, single-center trial. International Journal of Cardiology. 2017; 231: 248\u2013254.","DOI":"10.1016\/j.ijcard.2016.12.005"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/23\/1\/10.31083\/j.rcm2301020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T17:25:41Z","timestamp":1732728341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/23\/1\/10.31083\/j.rcm2301020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,14]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"alternative-id":["S1530-6550(22)00307-6"],"URL":"https:\/\/doi.org\/10.31083\/j.rcm2301020","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,14]]},"article-number":"20"}}